[Reporter’s View] Should hair loss be covered?

Discussions on extending National Health Insurance coverage to hair loss treatment have become a topic of political debate. Supporters argue that coverage is necessary to improve the quality of life for younger people, while critics question whether limited health insurance resources should be used for conditions that are not directly life-threatening.

The impact of hair loss on individuals is far from trivial. Beyond the stress of physical appearance, concerns about looks have a profound impact on social interactions, interpersonal relationships, and overall mental well-being. For younger people who are particularly sensitive to appearance, hair loss may be a quality-of-life issue rather than simply a cosmetic concern.

However, the National Health Insurance system is fundamentally a social safety net designed to protect life and health rather than improve the quality of life. If resources were unlimited, coverage could be expanded to include hair loss and many other conditions, but in real life, financial resources are constrained.

According to the National Assembly Budget Office, the National Health Insurance system is expected to move into deficit this year, with the deficit projected to reach KRW 39 trillion by 2035. And expenditures continue to rise due to population aging and the introduction of innovative medicines. Ultimately, the insurance system must decide what to prioritize.

From this perspective, the frustration felt by patients with severe and rare diseases is understandable. Cancer patients and those with rare diseases often miss optimal treatment windows due to delayed reimbursement decisions or pay hundreds to thousands of dollars out of pocket every month for non-reimbursed therapies. Many are forced to discontinue treatment because of financial burdens.

Dozens of petitions calling for expanded reimbursement coverage of treatments for severe and rare diseases have been submitted over the past year through the National Assembly's petition platform and the government's Petition24 system. Patients and their families continue appeals for better access to life-saving therapies. As a result, when the government signaled that it would prioritize reviewing reimbursement coverage for hair loss treatment, criticism quickly emerged, saying, “Why is hair loss drug coverage being prioritized when review for life-saving treatments continues to be delayed due to budget constraints?”

Of course, there is no reason to unconditionally oppose reimbursement for hair loss treatments. However, what we need right now is not poll results or political popularity, but a social consensus on the principles that the national health insurance must uphold.

Health insurance resources are limited, and priorities must be clear. Strengthening coverage for life-saving therapies and ensuring that patients with severe and rare diseases are not forced to abandon treatment should come first.  Only after those priorities are addressed should discussions move toward expanding coverage for quality-of-life improvements.

This is not to suggest that hair loss is unimportant. Rather, it is a reminder to reconsider the fundamental purpose of the National Health Insurance system. The question the government must answer is not “We should support hair loss because patients suffer,” but rather “Who should be helped first with the finite amount of resources?”

Once the priorities of the National Health Insurance system begin to blur, the greatest harm may ultimately fall on those patients who most urgently need reimbursement support.